Preference for United States Industry. During the period of exclusivity of this license in the United States, Licensee shall comply with 37 C.F.R. § 401.14 (i) or any successor rule or regulation.
Appears in 11 contracts
Sources: License Agreement (AVROBIO, Inc.), License Agreement, License Agreement (Sana Biotechnology, Inc.)
Preference for United States Industry. During the period of exclusivity of this license in the United States, Licensee LICENSEE shall comply with 37 C.F.R. § 401.14 (i) or any successor rule or regulation.
Appears in 1 contract
Sources: License Agreement (Gatc Health Corp)
Preference for United States Industry. During the period of exclusivity of this license in the United States, Licensee shall comply with 37 C.F.R. § 401.14 (i) or any successor rule or regulation. Upon Licensee’s request, Licensors agree to make reasonable efforts to assist Licensee in obtaining a waiver of the requirements imposed by such rules or regulations.
Appears in 1 contract
Sources: License Agreement (Tetralogic Pharmaceuticals Corp)
Preference for United States Industry. During the period of exclusivity of this license in the United States, Licensee shall comply with 37 C.F.R. § 401.14 (i) or any successor rule or regulation. Upon Licensee’s request, ▇▇▇▇▇▇ agrees to make reasonable efforts to assist Licensee in obtaining a waiver of the requirements imposed by such rules or regulations.
Appears in 1 contract
Preference for United States Industry. During the period of exclusivity of this license in the United States, Licensee shall comply with 37 C.F.R. § 401.14 (i) or any successor rule or regulationregu- lation.
Appears in 1 contract